Wednesday November 25, 2015 1:00pm to 1:00pm
QDM invites you to join a webinar on Wednesday November 25, 2015 at 1 p.m. EST to know everything about the $14M offered to academia and SMEs for R&D projects that accelerate drug discovery and development. Five (5) funding programs are currently open (see below) for the development of tools, technologies and platforms that can have an impact on biopharmaceutical research.
Programs currently opened :
- Focus on Brain (in collaboration with Brain Canada):
Funds the development of cutting-edge technologies, platforms or tools that will have an immediate and strong impact on the R&D process of new drugs for disorders of the brain, nervous system and special senses.
Maximum $1.5M/project. Deadline for letter of intent: December 15, 2015.
- Canada/Europe Joint Funding Initiative (in collaboration with European partners):
Funds collaborative R&D projects between researchers from the two countries involved (development of tools, technologies and platforms that accelerate drug discovery). CQDM can also help you find the right partner.
o Canada/Germany Program: Maximum $1M/project. Deadline for full application: January 15, 2016;
o Canada/Wallonia (Belgium) Program: Maximum $1.4M/project. Deadline for letter of intent: January 8, 2016;
o Canada/France Program: Maximum $1.4M/project. Open all year long.
- Quantum Leap :
This program allows SMEs and academia to develop platforms that will have a tremendous impact on biopharmaceutical research, in addition to meeting the critical needs of the industry. The program therefore aims at bringing an existing platform further while positioning it advantageously for commercialization. Budget depends on research proposal. Open all year long.
Sign up for the webinar here :
Once registered, you will receive a confirmation email including all the information about how to access the webinar. Please note that the webinar will be given in English.